Links on this page to third party websites are not under the editorial control of Fugent, LLC. The hyperlinks on this page are not an express or implied endorsement or approval by Fugent, LLC, of any products, services or information available from any third party site. For further information on third party content, please see our terms of use.

  1. List of Cell Lines transfected with FuGENE®HD
  2. Transfection of T47D mammary carcinoma cells using FuGENE®HD. (Biochemica 1/2008, pages 19-20.)
  3. Optimization of transfection conditions for gene expression, siRNA knock-down, and live cell imaging using FuGENE®HD. (Biochemica 1/2008, pages 21-24)
  4. High-performance shRNA-based gene knockdown using FuGENE®HD. (Biochemica 2/2008, pages 15-18)
  5. FuGENE®HD Transfection Reagent Superior Performance. (Biochemica 3/2006, pages 26-27)
  6. Functional Analysis of Transfection Reagents in the context of bax-induced apoptosis. (Cellular Analysis Application Note No. 3)
  7. Advances in transfection technologies using FuGENE®HD with pcr constructs. (Biochemica 4/2007, pages 22-25)
  8. Optimized production of lentivirus using FuGENE®HD. (BioTechniquesProtocol Guide 2009 (p. 31))
  9. Efficient transfection of primary human skeletal myoblasts using FuGENE®HD (Biochemica 3/2007, pages 26-27)
  10. Transfection of human tooth-specific lineage cells with FuGENE®HD. (Biochemica 3/2008, pages 14-16)
  11. Superior transfection of embryonic stem cells with FuGENE®HD. (Biochemica 4/2006, pages 19-21)
  12. Efficacy comparison of transfection reagents in a collecting duct cell line. (Biochemica 3/2007, pages 30-31)
  13. Efficient transfection of VeroE6 cells with DNA and RNA for luciferase reporter assays using FuGENE®HD. (Biochemica 2/2008, pages 12-14.)
  14. Efficient transfection of 293T cell line with lentiviral vectors using FuGENE®HD. (Biochemica 3/2007, pages 28-29)
  15. HD provides high levels of protein expression in human cell line HEK-293 EBNA and in high five insect cells. (Biochemica 1/2006, pages 20-21)
  16. Transfection of androgen responsive luciferase reporter vectors with FuGENE® FuGENE®HD Transfection Reagent in LNCaP and 22Rv1. (Cancer Res. 2009 Apr 1;69(7):2941-9. doi: 10.1158/0008-5472.CAN-08-3760. Epub 2009 Mar 24.)
  17. Analysis of RNA Polymerase II Mutants. (xCELLigence System Real-Time Cell Analyzer. Focus Application,
    Cellular Analysis. 2013)
  18. HD provides high transfection efficiency in the murine NB2a cell line. (Biochemica 4/2007, pages 20-21)
  19. Enabling cancer research with FuGENE®HD. (Biochemica 2/2007, pages 26-29)
  20. Effects of passage number on cell line transfection. (Biochemica 3/2007, pages 32)
  21. FuGENE®HD Choice of a Transfection Reagent with Minimal Off-Target Effect as Analyzed by Microarray Transcriptional Profiling. (Nature Methods 3. Application Notes. published online 17 October 2006)
  22. Efficient transfection of neuroblastoma cell lines using FuGENE®HD. (Biochemica 1/2007, pages 11-12)
  23. Apoptotic Effects of Caspase 8 Overexpression. (Cellular Analysis Application Note No. 1)
  24. Outstanding microarray experimental results using FuGENE®HD. (Biochemica 2/2009, pages 8-11)
  25. Optimization of transfection efficiency in chick embryo hepatocytes and HepG2 cells. (Biochemica 1/2007, pages 13-15)
  26. Optimization of transfection conditions for the human HL-60 promyelocytic leukemic t-cell line using FuGENE®HD. (Biochemica 3/2006, pages 24-25)
  27. Trichostatin A treatment of Cells transfected with FuGENE®HD. (Biochemica 2/2009, pages 6-7)
  28. Superiority of FuGENE®HD in minimizing non-specific cellular interferon response. (Biochemica 3/2006, pages 20-23)
  29. Transfecting Mouse Fibroblast NIH 3T3 Cells with Lipid Reagents – A Comparative Study. (Biochemica 4/2007, pages 18-19)
  30. Stable transgene expression in human embryonic stem cells after simple chemical transfection. (Molecular Reproduction and Development
    Volume 76, Issue 6, pages 580–586, June 2009)
  31. Rapid production of antigen-specific monoclonal antibodies from a variety of animals. (BMC Biology 2012, 10:80)
  32. Efficient in vivo gene delivery using modified Tat peptide with cationic lipids
  33. Multiplexed activation of endogenous genes by CRISPR-on, an RNA-guided transcriptional activator system
  34. Efficient chromosomal gene modification with CRISPR/cas9 and PCR-based homologous recombination donors in cultured Drosophila cells